Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on April 14, 2025

Vanilla Bean Market Set to Reach USD 2.96 Billion by 2034, Driven by Demand for Natural and Organic Products
Vanilla Bean Market Research Report By Application, By Type, By Form, By End Use and By Regional - Forecast to 2034 NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Vanilla Bean Market Size was estimated at 1.68 (USD Billion) in 2024. …

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …

Pineal Guard Under Review: Natural Pineal Gland Function Support
New York City, April 14, 2025 (GLOBE NEWSWIRE) -- Introduction: Reclaiming Clarity, Energy, and Balance In an age defined by overstimulation, digital overload, and mounting stress, many individuals are silently struggling with symptoms they cannot fully …

Lucas Blantford Dominates Super One Championship Opening Rounds with Elite Capital & Co. Backing
ROWRAH, CUMBRIA, UNITED KINGDOM, April 14, 2025 /EINPresswire.com/ -- Mr. Adrian Blantford, Principal Manager of Lucas Blantford Racing Team, announced today that Lucas Blantford delivered a masterclass performance at the 2025 Super One Championship, …

BioSyent to Attend Planet MicroCap Showcase
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …

Cue Biopharma Announces Proposed Public Offering
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Cue Biopharma to Host Business Update Call and Webcast
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Aurora Spine Announces the Resignation of Board Director James Snow
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …

Protein Packaging Market Surges with 4.01% CAGR Amid Rising Demand for Nutritional On-the-Go Products
The Protein Packaging Market Industry is being propelled by the increasing health consciousness among consumers who are prioritizing protein-rich diets. NEW YORK , NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The global protein packaging …

Sodium Lauryl Ether Sulfate Market Size Projected to Reach USD 6.16 Billion by 2034 with a CAGR of 3.24%
The increasing demand for personal care products, particularly in emerging economies, is a key Sodium Lauryl Ether Sulfate Market driver. NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The global Sodium Lauryl Ether Sulfate (SLES) market is on …

DGL Investments No. 1 Inc. Announces Proposed Qualifying Transaction with Rep Group Limited and Perspectives Productions Limited
Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, April 14, 2025 (GLOBE NEWSWIRE) -- DGL Investments No. 1 Inc. (“DGL” or the “Company”) (TSXV: DGL.P) is pleased to announce details …

Stran & Company Reports Financial Results for 2024 Fiscal Year
- 2023/2022 Financial Statements Re-audit Completed; Refocusing on Growth and Operational Initiatives - - Sales Increased 8.8% to $82.7 Million - - Conference Call Scheduled for Tuesday, April 15 at 11:00 A.M. ET - QUINCY, Mass., April 14, 2025 (GLOBE …

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2024 Financial Results
FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its …

my mimi Wins Best Sustainable Period Care Award 2025
VICTORIA, AUSTRALIA, April 14, 2025 /EINPresswire.com/ -- my mimi has been recognised as the ‘Best Sustainable Period Care Solution in Australia for 2025’*, thanks to its innovative and eco-conscious approach to menstrual health. At the heart of this …

Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 14 avr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …

Abacus Global Management to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025
ORLANDO, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced it will release its first quarter 2025 financial results after …

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter …